1-16055461-C-T
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000085.5(CLCNKB):c.1783C>T(p.Arg595*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,612,956 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000085.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Bartter disease type 3Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- Bartter disease type 4BInheritance: AR Classification: STRONG Submitted by: G2P
- Bartter syndrome type 4Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Gitelman syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CLCNKB | ENST00000375679.9 | c.1783C>T | p.Arg595* | stop_gained | Exon 17 of 20 | 1 | NM_000085.5 | ENSP00000364831.5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151804Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000959 AC: 24AN: 250332 AF XY: 0.0000884 show subpopulations
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1461152Hom.: 0 Cov.: 34 AF XY: 0.0000289 AC XY: 21AN XY: 726874 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151804Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74142 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Observed multiple times with another CLCNKB variant in unrelated patients with Bartter syndrome in published literature, but it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes in some cases (PMID: 17185149, 28381550); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 28288174, 28381550, 35628451, 17185149, 37516009)
This sequence change creates a premature translational stop signal (p.Arg595*) in the CLCNKB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CLCNKB are known to be pathogenic (PMID: 24830959, 26920127, 28381550, 29254190). This variant is present in population databases (rs370221310, gnomAD 0.05%). This premature translational stop signal has been observed in individuals with classic Bartter syndrome and Gitelman syndrome (PMID: 28381550). ClinVar contains an entry for this variant (Variation ID: 447098). For these reasons, this variant has been classified as Pathogenic.
Bartter disease type 3 Pathogenic:1
Bartter disease type 3;C4310805:Bartter disease type 4B Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at